Kenneth Jun Tao Li
Profile
Kenneth Jun Tao Li has been a Director of Wex Pharmaceuticals, Inc. since August 2005.
He is Managing Director of Genome & Associates Ltd.
He received a PhD in biochemistry from McGill University in 1978.
Former positions of Kenneth Jun Tao Li
| Companies | Position | End |
|---|---|---|
WEX Pharmaceuticals, Inc.
 WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada. | Director/Board Member | - |
Training of Kenneth Jun Tao Li
| McGill University | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
WEX Pharmaceuticals, Inc.
WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada. | Distribution Services |
- Stock Market
- Insiders
- Kenneth Jun Tao Li
